11-615010-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001572.5(IRF7):​c.184-3C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,542,680 control chromosomes in the GnomAD database, including 62,014 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 9295 hom., cov: 35)
Exomes 𝑓: 0.27 ( 52719 hom. )

Consequence

IRF7
NM_001572.5 splice_region, intron

Scores

2
Splicing: ADA: 0.2375
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.66

Publications

14 publications found
Variant links:
Genes affected
IRF7 (HGNC:6122): (interferon regulatory factor 7) This gene encodes interferon regulatory factor 7, a member of the interferon regulatory transcription factor (IRF) family. It has been shown to play a role in the transcriptional activation of virus-inducible cellular genes, including interferon beta chain genes. Inducible expression of IRF7 is largely restricted to lymphoid tissue. The encoded protein plays an important role in the innate immune response against DNA and RNA viruses. [provided by RefSeq, Jul 2021]
IRF7 Gene-Disease associations (from GenCC):
  • immunodeficiency 39
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 11-615010-G-T is Benign according to our data. Variant chr11-615010-G-T is described in ClinVar as [Benign]. Clinvar id is 1170390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.511 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF7NM_001572.5 linkc.184-3C>A splice_region_variant, intron_variant Intron 3 of 10 ENST00000525445.6 NP_001563.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF7ENST00000525445.6 linkc.184-3C>A splice_region_variant, intron_variant Intron 3 of 10 5 NM_001572.5 ENSP00000434009.2 Q92985-1

Frequencies

GnomAD3 genomes
AF:
0.324
AC:
49210
AN:
151888
Hom.:
9279
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.517
Gnomad AMI
AF:
0.205
Gnomad AMR
AF:
0.306
Gnomad ASJ
AF:
0.346
Gnomad EAS
AF:
0.0258
Gnomad SAS
AF:
0.131
Gnomad FIN
AF:
0.185
Gnomad MID
AF:
0.333
Gnomad NFE
AF:
0.270
Gnomad OTH
AF:
0.331
GnomAD2 exomes
AF:
0.250
AC:
40766
AN:
163132
AF XY:
0.241
show subpopulations
Gnomad AFR exome
AF:
0.513
Gnomad AMR exome
AF:
0.319
Gnomad ASJ exome
AF:
0.338
Gnomad EAS exome
AF:
0.0283
Gnomad FIN exome
AF:
0.187
Gnomad NFE exome
AF:
0.262
Gnomad OTH exome
AF:
0.256
GnomAD4 exome
AF:
0.266
AC:
369805
AN:
1390674
Hom.:
52719
Cov.:
37
AF XY:
0.261
AC XY:
179184
AN XY:
685366
show subpopulations
African (AFR)
AF:
0.522
AC:
16790
AN:
32174
American (AMR)
AF:
0.316
AC:
12303
AN:
38878
Ashkenazi Jewish (ASJ)
AF:
0.336
AC:
7688
AN:
22908
East Asian (EAS)
AF:
0.0224
AC:
860
AN:
38318
South Asian (SAS)
AF:
0.145
AC:
11246
AN:
77298
European-Finnish (FIN)
AF:
0.200
AC:
7360
AN:
36858
Middle Eastern (MID)
AF:
0.306
AC:
1703
AN:
5562
European-Non Finnish (NFE)
AF:
0.274
AC:
296141
AN:
1081022
Other (OTH)
AF:
0.273
AC:
15714
AN:
57656
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
15203
30406
45609
60812
76015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10170
20340
30510
40680
50850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.324
AC:
49262
AN:
152006
Hom.:
9295
Cov.:
35
AF XY:
0.313
AC XY:
23292
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.516
AC:
21374
AN:
41386
American (AMR)
AF:
0.306
AC:
4675
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.346
AC:
1200
AN:
3468
East Asian (EAS)
AF:
0.0258
AC:
134
AN:
5190
South Asian (SAS)
AF:
0.129
AC:
625
AN:
4832
European-Finnish (FIN)
AF:
0.185
AC:
1961
AN:
10610
Middle Eastern (MID)
AF:
0.341
AC:
99
AN:
290
European-Non Finnish (NFE)
AF:
0.270
AC:
18311
AN:
67930
Other (OTH)
AF:
0.330
AC:
696
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1678
3356
5035
6713
8391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.301
Hom.:
1409
Bravo
AF:
0.345
Asia WGS
AF:
0.127
AC:
440
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency 39 Benign:2
Jul 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 07, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 59% of patients studied by a panel of primary immunodeficiencies. Number of patients: 56. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
18
DANN
Benign
0.84
PhyloP100
1.7
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.24
dbscSNV1_RF
Benign
0.39
SpliceAI score (max)
0.35
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.35
Position offset: -26
DS_AL_spliceai
0.25
Position offset: -3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12290989; hg19: chr11-615010; API